El-Brolosy, M. A.; Oak, A.; Hoang, A. T.; Damergi, Y.; Fischer, A.; Saunders, R. A.; Luo, J.; Balabaki, A.; Guez, J.; Whitfield, T. W.et al.; Goldman, S. R.; Latifkar, A.; Lu, Y. R.; Stainier, D. Y. R.; Karczewski, K. J.; Corradin, O.; Weissman, J. S.: Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation. SCIENCE 391 (6786), eaea1272 (2026)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).